Oncolytics Biotech (TSE:ONC) Stock Crosses Above 200-Day Moving Average – What’s Next?

Oncolytics Biotech Inc. (TSE:ONC) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$14.90 and traded as high as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares traded.

Oncolytics Biotech Price Performance

The firm’s 50-day moving average price is C$14.90 and its two-hundred day moving average price is C$14.90. The stock has a market cap of C$1.50 billion, a PE ratio of -40.27 and a beta of 0.80. The company has a current ratio of 2.88, a quick ratio of 8.86 and a debt-to-equity ratio of 14.58.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc to co-develop pelareorep, as well as with Roche Holding AG.